Drug Discovery & Pharma Innovation
Drug Pricing Transparency Laws: Impact on Pharma Profitability
Over the past decade, the global pharmaceutical industry has come under increasing scrutiny for the way it prices its products….
Study Suggests Novo Nordisk’s Weight-Loss Drug May Better Preserve Muscle Than Lilly’s Tirzepatide
A new study indicates that Novo Nordisk’s semaglutide may preserve lean body mass more effectively than Eli Lilly’s tirzepatide, despite…
Eli Lilly’s Foundayo Pill Cuts Heart Attack and Stroke Risk in Late-Stage Study
Eli Lilly’s Foundayo Pill Cuts Heart Attack and Stroke Risk in Late-Stage Study Eli Lilly has reported that its newly…
AI Co-Pilots for Chemists: Revolutionizing Molecule Design
For decades, the art and science of molecule design has been a delicate balance between human intuition, experimental rigor, and…
Generative Biology: Designing Drugs Without Traditional Labs
For over a century, drug discovery has followed a familiar path—identify a biological target, screen thousands of compounds in physical…
HNL Lab Medicine Digital Pathology Platform Speeds Up Diagnoses and Enables Remote Work
April 2026 — HNL Lab Medicine, a laboratory partner affiliated with Lehigh Valley Health Network and part of Jefferson Health,…
Cancer Biosimilars: Falling Prices, Rising Hospital Margins
A new study published in JAMA has found that in the United States, hospital profits from cancer biosimilars have increased…
LB Pharmaceuticals Launches Phase 3 NOVA-2 Trial for Schizophrenia Treatment LB-102
LB Pharmaceuticals Inc., a late-stage biopharmaceutical company focused on developing treatments for neuropsychiatric disorders, has announced the initiation of its…
LB Pharmaceuticals Launches Phase 3 NOVA-2 Trial for Schizophrenia Treatment LB-102
LB Pharmaceuticals Inc., a late-stage biopharmaceutical company focused on developing treatments for neuropsychiatric disorders, has announced the initiation of its…
Generative AI in Drug Discovery & Trial Design
Generative AI is rapidly reshaping how new drugs are discovered and how clinical trials are designed—cutting years off timelines and…